A U.S.-BASED microbial sciences company setting a new standard of scientific rigour in the $70 billion global probiotics market, began shipping to Canada this summer.
Seed’s approach is a shift, bridging microbiome science and consumer health in an effort to bring precision, efficacy, and education to consumer probiotics. Their flagship product—Daily Synbiotic—a probiotic plus prebiotic formulation, is available to purchase as a monthly or quarterly subscription. It contains a proprietary formulation of 20-plus clinically studied probiotic strains (not found in yoghurt, or fermented foods) with a new class of organic, patented, plant-based, non-fermenting prebiotics sourced from Indian pomegranate and Scandinavian chaga and pine bark.
Following the U.S. launch, the Daily Synbiotic sold out in less than four months. Seed is led by Co-Founders and Co-CEOs, Ara Katz and Raja Dhir along with Chief Scientist Dr. Gregor Reid—a pioneer in probiotics research, who chaired the United Nations World Health Organization Expert Panel that authored the global definition of the term probiotics.